98 related articles for article (PubMed ID: 15208685)
1. Defining the temporal requirements for Myc in the progression and maintenance of skin neoplasia.
Flores I; Murphy DJ; Swigart LB; Knies U; Evan GI
Oncogene; 2004 Aug; 23(35):5923-30. PubMed ID: 15208685
[TBL] [Abstract][Full Text] [Related]
2. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis.
Waikel RL; Wang XJ; Roop DR
Oncogene; 1999 Aug; 18(34):4870-8. PubMed ID: 10490820
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of myc and telomerase interactions in vivo.
Flores I; Evan G; Blasco MA
Mol Cell Biol; 2006 Aug; 26(16):6130-8. PubMed ID: 16880523
[TBL] [Abstract][Full Text] [Related]
4. Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk.
Honda K; Sakaguchi T; Sakai K; Schmedt C; Ramirez A; Jorcano JL; Tarakhovsky A; Kamisoyama H; Sakai T
Carcinogenesis; 2007 Oct; 28(10):2074-81. PubMed ID: 17494055
[TBL] [Abstract][Full Text] [Related]
5. Omomyc expression in skin prevents Myc-induced papillomatosis.
Soucek L; Nasi S; Evan GI
Cell Death Differ; 2004 Sep; 11(9):1038-45. PubMed ID: 15143346
[TBL] [Abstract][Full Text] [Related]
6. Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.
Pelengaris S; Littlewood T; Khan M; Elia G; Evan G
Mol Cell; 1999 May; 3(5):565-77. PubMed ID: 10360173
[TBL] [Abstract][Full Text] [Related]
7. The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors.
Hansen LA; Woodson RL; Holbus S; Strain K; Lo YC; Yuspa SH
Cancer Res; 2000 Jul; 60(13):3328-32. PubMed ID: 10910032
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland.
Bull JJ; Pelengaris S; Hendrix S; Chronnell CM; Khan M; Philpott MP
Br J Dermatol; 2005 Jun; 152(6):1125-33. PubMed ID: 15948972
[TBL] [Abstract][Full Text] [Related]
9. Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.
Affara NI; Trempus CS; Schanbacher BL; Pei P; Mallery SR; Bauer JA; Robertson FM
Anticancer Res; 2006; 26(4B):2805-20. PubMed ID: 16886599
[TBL] [Abstract][Full Text] [Related]
10. Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes.
Brennan D; Hu Y; Joubeh S; Choi YW; Whitaker-Menezes D; O'Brien T; Uitto J; Rodeck U; Mahoney MG
J Cell Sci; 2007 Mar; 120(Pt 5):758-71. PubMed ID: 17284515
[TBL] [Abstract][Full Text] [Related]
11. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
12. Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.
Lawlor ER; Soucek L; Brown-Swigart L; Shchors K; Bialucha CU; Evan GI
Cancer Res; 2006 May; 66(9):4591-601. PubMed ID: 16651409
[TBL] [Abstract][Full Text] [Related]
13. An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesis.
Kim E; Rundhaug JE; Benavides F; Yang P; Newman RA; Fischer SM
Oncogene; 2005 Feb; 24(7):1174-87. PubMed ID: 15558016
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CCAAT/enhancer binding protein family DNA binding in mouse epidermis prevents and regresses papillomas.
Oh WJ; Rishi V; Orosz A; Gerdes MJ; Vinson C
Cancer Res; 2007 Feb; 67(4):1867-76. PubMed ID: 17308129
[TBL] [Abstract][Full Text] [Related]
15. Id2 is dispensable for Myc-induced epidermal neoplasia.
Murphy DJ; Swigart LB; Israel MA; Evan GI
Mol Cell Biol; 2004 Mar; 24(5):2083-90. PubMed ID: 14966287
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
[TBL] [Abstract][Full Text] [Related]
17. Sustained loss of a neoplastic phenotype by brief inactivation of MYC.
Jain M; Arvanitis C; Chu K; Dewey W; Leonhardt E; Trinh M; Sundberg CD; Bishop JM; Felsher DW
Science; 2002 Jul; 297(5578):102-4. PubMed ID: 12098700
[TBL] [Abstract][Full Text] [Related]
18. Brief inactivation of c-Myc is not sufficient for sustained regression of c-Myc-induced tumours of pancreatic islets and skin epidermis.
Pelengaris S; Abouna S; Cheung L; Ifandi V; Zervou S; Khan M
BMC Biol; 2004 Dec; 2():26. PubMed ID: 15613240
[TBL] [Abstract][Full Text] [Related]
19. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis.
Jansen AP; Camalier CE; Colburn NH
Cancer Res; 2005 Jul; 65(14):6034-41. PubMed ID: 16024603
[TBL] [Abstract][Full Text] [Related]
20. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
